Cincinnati Children's Appoints Vice President of Commercialization

"One of our top priorities at Cincinnati Children's is sharing our ideas, our discoveries and our advancements so that children in Cincinnati and around the world can thrive," said Margaret Hostetter, MD, director, Cincinnati Children's Research Foundation. "The interaction of our innovative faculty with the Center for Technology Commercialization is critical to our success in this arena, and I'm excited for what the CTC will accomplish under Andrew's leadership."

Wooten comes to Cincinnati Children's from Baylor College of Medicine, where he was the founding executive director, Innovation Development Center. Prior to that, he held positions in industry, academia, and as a biotechnology entrepreneur. Wooten received a B.A. in chemistry from Berea College, an M.S. in biotechnology from University of Georgia, and an M.B.A. from Mercer University.

"Andrew brings a wealth of experience and a successful track record of fostering a culture of innovation while translating innovative technologies from bench to bedside," said Jennifer Dauer, senior vice president, Strategy and Growth. "Andrew has spent much of his career at the intersection of academic research and industry and I'm confident in his ability to take our commercialization efforts to the next level."

"I'm excited to join a world-class clinical and research institution in Cincinnati Children's, with a rich history of transformational commercial successes," said Wooten. "My hope is to build on a great foundation with the CTC and elevate Cincinnati Children's pediatric innovation programs to even greater levels of success. I look forward to working with our innovators, the regional ecosystem, and our partners in industry and venture to continue to do everything we can to be the leader in improving child health."  

SOURCE Cincinnati Children's Hospital Medical Center

Related Links

http://www.cincinnatichildrens.org